Activation of TRPV1 enhanced mRNA level and protein level of IL-6 in FLS from RA and OA patient and application of TRPV1 antagonist could be therapeutic strategy to modulate nociception from arthritis.73 The gene discussed is TRPV1; the disease is rheumatoid arthritis.